Obesity & GLP-1 is a rules-based basket of 4 US-listed stocks — The metabolic-health wave — GLP-1 makers and the distribution around them.. 731.1% backtested total return, +566.2% vs the S&P 500 since inception. Equal-weight, point-in-time, survivorship-corrected. Published for US investors. Not investment advice.
| Ticker | Company | Weight |
|---|---|---|
| LLY | Eli Lilly and Company | 25.0% |
| VKTX | Viking Therapeutics, Inc. | 25.0% |
| AMGN | Amgen Inc. | 25.0% |
| HIMS | Hims & Hers Health, Inc. | 25.0% |
Performance shown is backtested (hypothetical), not actual trades, benchmarked to the S&P 500 total return. Past performance does not guarantee future results. Signals is a publisher, not a broker or investment adviser. US users only.